CAROTTI, SIMONE
 Distribuzione geografica
Continente #
AS - Asia 7.609
NA - Nord America 1.202
SA - Sud America 577
EU - Europa 531
AF - Africa 40
OC - Oceania 20
Totale 9.979
Nazione #
SG - Singapore 5.923
US - Stati Uniti d'America 1.130
CN - Cina 695
HK - Hong Kong 556
BR - Brasile 448
VN - Vietnam 270
IT - Italia 163
GB - Regno Unito 114
DE - Germania 88
AR - Argentina 48
CA - Canada 37
ID - Indonesia 32
NL - Olanda 30
IN - India 28
MX - Messico 26
BD - Bangladesh 24
EC - Ecuador 24
TR - Turchia 21
FI - Finlandia 20
ZA - Sudafrica 20
AU - Australia 19
PL - Polonia 19
UA - Ucraina 19
PY - Paraguay 18
JP - Giappone 15
CO - Colombia 13
ES - Italia 11
RU - Federazione Russa 11
CL - Cile 10
MA - Marocco 9
CZ - Repubblica Ceca 8
FR - Francia 8
PE - Perù 8
LU - Lussemburgo 5
PK - Pakistan 5
RS - Serbia 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CR - Costa Rica 4
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
LV - Lettonia 3
SE - Svezia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
IQ - Iraq 2
LB - Libano 2
PH - Filippine 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BJ - Benin 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GN - Guinea 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
UY - Uruguay 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
Totale 9.979
Città #
Hong Kong 547
Singapore 421
Ashburn 288
Hefei 279
Boardman 157
Dallas 142
Beijing 135
Ho Chi Minh City 102
London 92
Shanghai 90
Rome 58
Los Angeles 53
Hanoi 48
São Paulo 41
Munich 32
San Francisco 32
Santa Clara 32
Guangzhou 30
Council Bluffs 23
Rio de Janeiro 21
New York 19
Toronto 18
Warsaw 16
Amsterdam 15
Da Nang 15
Washington 14
Boston 12
Turku 12
West Jordan 12
Curitiba 11
Haiphong 11
Hải Dương 11
Mexico City 11
Brooklyn 10
Charlotte 10
Guayaquil 10
Seattle 10
Shenzhen 10
Canberra 9
Montreal 9
Pune 9
Tokyo 9
Brasília 8
Can Tho 8
Helsinki 8
Xi'an 8
Biên Hòa 7
Brno 7
Guarulhos 7
Johannesburg 7
Lima 7
Redmond 7
Chicago 6
Melbourne 6
Milan 6
Seriate 6
Sona 6
Acireale 5
Asunción 5
Atlanta 5
Boydton 5
Buenos Aires 5
Casablanca 5
Central 5
Chennai 5
Dhaka 5
Karachi 5
Phoenix 5
Quito 5
Thái Bình 5
Thái Nguyên 5
Anápolis 4
Bogotá 4
Bắc Giang 4
Campinas 4
Changsha 4
Esch-sur-Alzette 4
Fortaleza 4
Frankfurt am Main 4
Jakarta 4
Kars 4
Las Vegas 4
Montes Claros 4
Naples 4
Ninh Bình 4
Osasco 4
Porto Alegre 4
Providence 4
Recife 4
Salvador 4
Santo André 4
Uberlândia 4
Araruama 3
Ashford 3
Bangkok 3
Belo Horizonte 3
Belém 3
Bratislava 3
Bắc Ninh 3
Concon 3
Totale 3.168
Nome #
Activated Kupffer Cells are associated with fibrosis and angiogenesis in liver metastasis from colorectal carcinoma 222
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 218
Expression of estrogen receptors in spitz and reed nevi 218
Exploring Tumor Heterogeneity: Radiogenomic Assessment of ADFP in Low WHO/ISUP Grade Clear Cell Renal Cell Carcinoma 216
ACTIVATED KUPFFER CELLS ARE ASSOCIATED WITH FIBROSIS AND ANGIOGENESIS IN COLORECTAL CARCINOME METASTASIS 216
Anatomy & Physiology - The Unity of Form and Function _ Fifth Edition 215
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 207
Colonic mucosa exposure to pathogenic lipopolysaccharide induces impairment of smooth muscle cells contraction 207
Detection of proximal esophageal acid exposure enhances sensitivity of PH test in non erosive gastroesophageal reflux disease patients 202
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 200
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo 197
DECREASED NUMBER OF ACTIVATED MACROPHAGES IN GALLBLADDER MUSCLE LAYER OF CHOLESTEROL GALLSTONES PATIENTS FOLLOWUING URSODEOXYCHOLIC ACID 195
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 195
Impaired Human Colonic Contractility and Toll-Like Receptor 4 (TLR4) Expression in Uncomplicated Diverticular Disease 194
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 193
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 191
IMPAIRED HUMAN COLONIC CONTRACTILITY AND TOLL-LIKE RECEPTOR 4 (TLR4) EXPRESSION IN UNCOMPLICATED DIVERTICULAR DISEASE 189
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies 186
Electrospun hydroxyapatite-functionalized PLLA scaffold: potential applications in sternal bone healing 186
Anti-tumor necrosis alpha reverts growth hormone resistance associated with inflammatory bowel disease 185
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 184
The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies 182
Capsular contracture: angiogenesis and role of estrogen receptor in periprosthetic tissue remodeling 181
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 138
Activated muscularis macrophages contribute to muscle cell dysfunction in cholesterol gallstone patients 119
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 116
Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a Friedreich’s ataxia mouse model 109
Pain in Parkinson's disease: a neuroanatomy-based approach 102
Anatomy and Embryology of the Liver 101
Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid 100
Computer fluid dynamics of post-prandial gallbladder bile flow in gallstone patients: effect of short-term therapy with ursodeossicolic acid 100
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 99
Cathelicidin LL-37 Expression in Human Breast Implant Capsules 97
Anti-oxidant mechanism of ursodeoxycholic acid on gallbladder muscle cells from symptomatic gallstone patients 95
DIETARY CONCENTRATIONS OF PALMITIC ACID AFFECT GUT EPITHELIAL INTEGRITY 94
DECREASED NUMBER OF ACTIVATED MACROPHAGES IN GALLBLADDER MUSCLE LAYER OF CHOLESTEROL GALLSTONE PATIENTS FOLLOWING URSODEOXICHOLIC ACID 86
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 76
Anti-tumor necrosis factor alpha reverts growth hormone resistance associated with inflammatory bowel disease 76
Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon 76
Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists 76
Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders 75
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 71
Exploring the role of Fragile X Mental Retardation Protein in melanoma progression and invasiveness-related pathways in melanoma cells 70
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 69
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 68
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 68
Rewriting the MASLD‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism 65
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 64
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 60
MACanalyzeR scRNAseq analysis tool reveals PPARγHIGH/GDF15HIGH lipid-associated macrophages facilitate thermogenic expansion in BAT 59
Frataxin deficiency induces lipid accumulation and affects thermogenesis in brown adipose tissue 56
Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin 54
Liver Histology 51
The role of angiogenesis, inflammation and estrogen receptors in breast implant capsules development and remodeling 50
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 47
Reelin expression in human liver of patients with chronic hepatitis C infection 46
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 46
Identification of matrix metalloprotease 10 (mmp10) as a key new mediator of the regenerative response of the liver 45
Histological and Immunohistochemical Evaluation of Human Breast Capsules Formed Around Five Different Expander Surfaces 44
Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation 44
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 43
The Fragile X Mental Retardation Protein regulates tumor invasiveness-related pathways in melanoma cells 42
Estrogen receptors alpha and beta expression in breast implant capsules: experimental findings and clinical correlates 42
Hepatic progenitor niche activation as histological predictor of graft survival in liver transplantation. 42
Free-Form Fabrication Of Biopolymeric Scaffolds For Osteochondral Segment Regeneration 41
Hepatic progenitor niche attivation as histological predictor of graft survival in liver transplantation 40
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice 40
Regeneration Of Osteochondral Segment Via Mesenchymal Stem Cells Culturing On 3D Rapid Prototyped Scaffolds 40
Identification of Fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure 40
GFAP expression in hepatic stellate cells may predicts fibrosis progression in post-transplant recurrent hepatitis C 39
GFAP EXPRESSION IN HEPATIC STELLATE CELLS MAY PREDICT FIBROSIS PROGRESSION IN POST-TRANSPLNT RECURRENT HEPATITIS C 39
Rapid prototyping of bioactive scaffolds for the regeneration of osteochondral tissue 39
Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis 39
Lipid-associated macrophages reshape BAT cell identity in obesity 38
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development 38
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 38
Portal and interface chronic inflammation are associated with the progenitor cell compartment activation during NAFLD 38
Hepatic Progenitor Cells and Biliary Tree Stem Cells 37
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
IMMUNOHISTOCHEMICAL STUDY ON THE RESPONSE OF SURROUNDING LIVER TO COLORECTAL CARCINOMA LIVER METASTASIS 37
Matrix metalloproteinase-10 contributes to hepatocellular carcinoma development in a novel crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis 37
Effect of short-time treatment with ursodeoxicolic acid on postprandial gallbladder bile flow in gallstone patients: a statistical -mathematical analysis of ultrasonographic data 37
Dilated Intercellular Spaces in Non Erosive Reflux Disease Patients with Physiological Esophageal Acid Exposure 37
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 36
Oestrogen receptor-alpha and -beta expression in breast implant capsules: experimental findings and clinical correlates 36
MMP10 EXPRESSION PROTECTS FROM ACUTE LIVER INJURY BUT CONTRIBUTES TO HEPATOCELLULAR CARCINOMA PROGRESSION 36
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver injury 36
Ursodeoxycholic acid improves gallbladder muscle contractility and reduces the oxidative stress in patients with cholesterol stones 36
Dynamic magnetic resonance imaging enhancement patterns of the bowel wall correlate with clinical and inflammatory activity in Crohn’s disease 36
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 35
Reelin expression in liver and pancreas and its correlation with liver fibrosis 35
Liver vitamin D receptor, CYP2R1 and CYP27A1 expression related to progression of metabolic and viral liver damage 35
Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas and glucose levels of non obese diabetic (NOD) mouse 35
GFAP EXPRESSION IN HEPATIC STELLATE CELLS IS RELATED TO VASCULAR REMODELLING DURING HEPATIC CHRONIC DESEASES 35
Hepatic complications of bariatric surgery : the reverse side of the coin 34
GFAP expression: an early marker of stellate and endothelial cells activation in the liver 34
Dilated Intercellular Spaces in Non Erosive Reflux Disease Patients with Physiological Esophageal Acid Exposure 34
TOOL-LIKE RECEPTOR-4 EXPRESSION BY HEPATIC PROGENITOR CELLS AND BILIARY EPITHELIAL CELLS IN HCV-RELATED CHRONIC LIVER DISEASE 34
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 33
The hepatic expression of GH/IGF1 axis components is impaired with fibrosis progression in patients with HCV-related chronic hepatitis 33
Totale 8.884
Categoria #
all - tutte 62.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022247 0 0 17 0 9 4 0 0 15 3 0 199
2022/202364 3 1 3 4 5 0 1 8 4 19 16 0
2023/2024433 14 34 18 29 49 202 0 21 8 27 13 18
2024/20256.950 80 52 200 18 73 108 110 33 338 454 2.658 2.826
2025/20262.342 482 316 420 811 200 113 0 0 0 0 0 0
Totale 10.036